Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05837936
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-04-03
Brief Title:
Total Intravenous Anesthesia TIVASevoflurane Initiated Intravenous Anesthesia SIIVA in Pediatric Patients
Sponsor:
Wake Forest University Health Sciences
Organization:
Wake Forest University Health Sciences
Study Overview
Official Title:
A Prospective Observational Study Evaluating Extubation Criteria in Children Less 10 Years of Age and Younger Undergoing Intravenous Anesthesia
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Because Propofol is the primary anesthetic agent and inhalational agents remain in trace quantities at the end of the procedure Sevoflurane initiated intravenous anesthesia SIIVA or not present at all Total intravenous anesthesia TIVA it is likely that different criteria may be predictive of extubation success in these patients compared to inhalational anesthesia
Detailed Description:
This is because these anesthetic regimens have different pharmacologic mechanisms of actions and therefore interact with central nervous system in different ways leading to potentially the need for different extubation criteria in patients receiving TIVA or SIIVA Additionally intravenous agents likely have less of an effect on airway reflexes and ventilation at light levels of anesthesia This study is proposing an observational study to examine the predictive value of various extubation criteria in the setting of SIIVA and TIVA
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None